Wells Fargo’s OncoSec Medical Incorporated ONCS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,929
| Closed | -$4.98K | – | 7822 |
|
|
2023
Q1 | $4.98K | Buy |
1,929
+1,923
| +32,050% | +$3.82K | ﹤0.01% | 6056 |
|
|
2022
Q4 | $10 | Hold |
6
| – | – | ﹤0.01% | 7379 |
|
|
2022
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 7949 |
|
|
2022
Q2 | $0 | Buy |
6
+1
| +20% | +$19 | ﹤0.01% | 8045 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 8376 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 8328 |
|
|
2021
Q3 | $0 | Sell |
5
-2
| -29% | -$101 | ﹤0.01% | 7965 |
|
|
2021
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 7921 |
|
|
2021
Q1 | $1K | Buy |
7
+3
| +75% | +$411 | ﹤0.01% | 6833 |
|
|
2020
Q4 | $1K | Buy |
4
+1
| +33% | +$107 | ﹤0.01% | 6420 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 7345 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 7260 |
|
|
2020
Q1 | $0 | Sell |
3
-20
| -87% | -$747 | ﹤0.01% | 7300 |
|
|
2019
Q4 | $1K | Hold |
23
| – | – | ﹤0.01% | 6312 |
|
|
2019
Q3 | $1K | Sell |
23
-9
| -28% | -$422 | ﹤0.01% | 6337 |
|
|
2019
Q2 | $2K | Buy |
32
+23
| +256% | +$2.21K | ﹤0.01% | 6216 |
|
|
2019
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 5994 |
|
|
2018
Q4 | $1K | Sell |
9
-28
| -76% | -$7.04K | ﹤0.01% | 6343 |
|
|
2018
Q3 | $11K | Sell |
37
-75
| -67% | -$23.1K | ﹤0.01% | 5980 |
|
|
2018
Q2 | $34K | Sell |
112
-4
| -3% | -$1.4K | ﹤0.01% | 5702 |
|
|
2018
Q1 | $48K | Buy |
116
+41
| +55% | +$16.8K | ﹤0.01% | 5577 |
|
|
2017
Q4 | $27K | Buy |
+75
| New | +$26.3K | ﹤0.01% | 5719 |
|
Wells Fargo's ONCS Position: Q2 2023 in Review
Wells Fargo sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 1,929 shares — an estimated $4.98K sold.
Wells Fargo first reported a position in ONCS in Q4 2017 and held it in 22 quarters. The position peaked at $48K in Q1 2018. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.
- Wells Fargo reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
- Wells Fargo sold 1,929 OncoSec Medical Incorporated shares in Q2 2023, an estimated $4.98K.
- Wells Fargo first reported a position in OncoSec Medical Incorporated in Q4 2017 and held it in 22 quarters.
- Wells Fargo's OncoSec Medical Incorporated position peaked at $48K in Q1 2018.
- 0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.
Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.